{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:55:16Z","timestamp":1781718916865,"version":"3.54.5"},"reference-count":34,"publisher":"American Veterinary Medical Association (AVMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2026,7,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate survival outcomes, complication rates, and prognostic factors for dogs and cats with urothelial carcinoma (UC) treated with partial cystectomy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Medical records of client-owned dogs and cats with UC treated with partial cystectomy between January 2010 and December 2024 were retrospectively reviewed. Data regarding signalment, tumor and surgical characteristics, adjuvant therapy, and outcomes were collected. Disease-free interval and median survival time (MST) were estimated via the Kaplan-Meier method. Prognostic factors were identified with log-rank tests and Cox proportional hazards modeling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>30 animals were included (20 dogs, 10 cats). Overall MST for 27 patients was 512 days and disease-free interval was 255 days. Mean survival time was 498 days for dogs and 730 days for cats. Complete surgical margins were associated with longer MST on univariate analysis. On multivariate analysis, complete surgical margins (hazard ratio, 0.27) and adjuvant chemotherapy (hazard ratio, 0.24) were independent positive prognostic factors. Postoperative complications occurred in 16 of 30 patients (53%). Local recurrence was documented in 12 patients (40%) and distant metastasis in 5 patients (17%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Partial cystectomy, as part of a multimodal treatment plan including adjuvant medical therapy, can be associated with prolonged survival in select dogs and cats with nontrigonal UC. The achievement of complete surgical margins is a critical predictor of outcome.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>The procedure carries a substantial risk of complications and eventual disease progression, underscoring the importance of careful case selection and comprehensive client counseling regarding the palliative intent of therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2460\/javma.25.11.0721","type":"journal-article","created":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T17:18:55Z","timestamp":1773422335000},"page":"1-7","source":"Crossref","is-referenced-by-count":0,"title":["Partial cystectomy and adjuvant chemotherapy are associated with prolonged survival in dogs and cats with nontrigonal urothelial carcinoma (2010\u20132014)"],"prefix":"10.2460","volume":"264","author":[{"given":"Dilraj Singh","family":"Goraya","sequence":"first","affiliation":[{"name":"Angell Animal Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Cray","sequence":"additional","affiliation":[{"name":"Angell Animal Medical Center, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"18","key":"ref1","series-title":"Animals (Basel).","first-page":"2896","article-title":"A systematic review of canine cystectomy: indications, techniques, and outcomes","volume":"13","author":"Hildebrandt I","year":"2023","unstructured":"Hildebrandt I, Culp WTN, Griffin MA. A systematic review of canine cystectomy: indications, techniques, and outcomes. Animals (Basel). 2023;13(18):2896. doi:10.3390\/ani13182896"},{"key":"ref2","article-title":"Withrow and MacEwen\u2019s Small Animal Clinical Oncology","author":"Withrow SJ","year":"2019","unstructured":"Withrow SJ, Vail DM, Page RL. Withrow and MacEwen\u2019s Small Animal Clinical Oncology. 6th ed. Elsevier; 2019."},{"issue":"4","key":"ref3","series-title":"J Vet Intern Med.","first-page":"273","article-title":"Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder","volume":"8","author":"Knapp DW","year":"1994","unstructured":"Knapp DW, Richardson RC, Chan TC,  Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111\/j.1939-1676.1994.tb03232.x"},{"issue":"1","key":"ref4","series-title":"J Vet Intern Med.","first-page":"274","article-title":"Lower urinary tract transitional cell carcinoma in cats: clinical findings, treatments, and outcomes in 118 cases","volume":"34","author":"Griffin MA","year":"2020","unstructured":"Griffin MA, Culp WTN, Giuffrida MA,  Lower urinary tract transitional cell carcinoma in cats: clinical findings, treatments, and outcomes in 118 cases. J Vet Intern Med. 2020;34(1):274-282. doi:10.1111\/jvim.15656"},{"issue":"1","key":"ref5","series-title":"J Am Vet Med Assoc.","first-page":"101","article-title":"Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004)","volume":"231","author":"Wilson HM","year":"2007","unstructured":"Wilson HM, Chun R, Larson VS, Kurzman ID, Vail DM. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004). J Am Vet Med Assoc. 2007;231(1):101-106. doi:10.2460\/javma.231.1.101"},{"issue":"4","key":"ref6","series-title":"Vet Comp Oncol.","first-page":"1417","article-title":"Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder","volume":"15","author":"Marvel SJ","year":"2017","unstructured":"Marvel SJ, S\u00e9guin B, Dailey DD, Thamm DH. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder. Vet Comp Oncol. 2017;15(4):1417-1427. doi:10.1111\/vco.12286"},{"issue":"6","key":"ref7","series-title":"Mol Cancer Res.","first-page":"993","article-title":"Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer\u2014evidence for a relevant model system and urine-based diagnostic test","volume":"13","author":"Decker B","year":"2015","unstructured":"Decker B, Parker HG, Dhawan D,  Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer\u2014evidence for a relevant model system and urine-based diagnostic test. Mol Cancer Res. 2015;13(6):993-1002. doi:10.1158\/1541-7786.MCR-14-0689"},{"issue":"6","key":"ref8","series-title":"PLoS One.","first-page":"e0129534","article-title":"BRAF mutations in canine cancers","volume":"10","author":"Mochizuki H","year":"2015","unstructured":"Mochizuki H, Kennedy K, Shapiro SG, Breen M. BRAF mutations in canine cancers. PLoS One. 2015;10(6):e0129534. doi:10.1371\/journal.pone.0129534"},{"issue":"2","key":"ref9","series-title":"Vet Comp Oncol.","first-page":"73","article-title":"Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder","volume":"3","author":"Boria PA","year":"2005","unstructured":"Boria PA, Glickman NW, Schmidt BR,  Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder. Vet Comp Oncol. 2005;3(2):73-80. doi:10.1111\/j.1476-5810.2005.00070.x"},{"issue":"6","key":"ref10","series-title":"J Vet Intern Med.","first-page":"1385","article-title":"Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder","volume":"25","author":"Arnold EJ","year":"2011","unstructured":"Arnold EJ, Childress MO, Fourez LM,  Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 2011;25(6):1385-1390. doi:10.1111\/j.1939-1676.2011.00796.x"},{"issue":"10","key":"ref11","series-title":"J Small Anim Pract.","first-page":"480","article-title":"Partial cystectomy for urinary bladder neoplasia: surgical technique and outcome in 11 dogs","volume":"37","author":"Stone EA","year":"1996","unstructured":"Stone EA, George TF, Gilson SD, Page RL. Partial cystectomy for urinary bladder neoplasia: surgical technique and outcome in 11 dogs. J Small Anim Pract. 1996;37(10):480-485. doi:10.1111\/j.1748-5827.1996.tb01745.x"},{"issue":"3","key":"ref12","series-title":"J Vet Intern Med.","first-page":"145","article-title":"Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985)","volume":"6","author":"Norris AM","year":"1992","unstructured":"Norris AM, Laing EJ, Valli VE,  Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med. 1992;6(3):145-153. doi:10.1111\/j.1939-1676.1992.tb00330.x"},{"issue":"2","key":"ref13","series-title":"Can Vet J.","first-page":"133","article-title":"Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy","volume":"62","author":"Bradbury ML","year":"2021","unstructured":"Bradbury ML, Mullin CM, Gillian SD,  Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy. Can Vet J. 2021;62(2):133-140."},{"issue":"2","key":"ref14","series-title":"Vet J.","first-page":"217","article-title":"Management of transitional cell carcinoma of the urinary bladder in dogs: a review","volume":"205","author":"Fulkerson CM","year":"2015","unstructured":"Fulkerson CM, Knapp DW. Management of transitional cell carcinoma of the urinary bladder in dogs: a review. Vet J. 2015;205(2):217-225. doi:10.1016\/j.tvjl.2015.01.017"},{"issue":"2","key":"ref15","series-title":"J Am Anim Hosp Assoc.","first-page":"131","article-title":"Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study","volume":"40","author":"Poirier VJ","year":"2004","unstructured":"Poirier VJ, Forrest LJ, Adams WM, Vail DM. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. J Am Anim Hosp Assoc. 2004;40(2):131-136. doi:10.5326\/0400131"},{"issue":"11","key":"ref16","series-title":"J Am Vet Med Assoc.","first-page":"1534","article-title":"Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma","volume":"242","author":"Schrempp DR","year":"2013","unstructured":"Schrempp DR, Childress MO, Stewart JC,  Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma. J Am Vet Med Assoc. 2013;242(11):1534-1538. doi:10.2460\/javma.242.11.1534"},{"key":"ref17","article-title":"Tumors in Domestic Animals","author":"Meuten DJ","year":"2017","unstructured":"Meuten DJ, ed. Tumors in Domestic Animals. 5th ed. John Wiley and Sons; 2017."},{"issue":"18","key":"ref1","series-title":"Animals (Basel).","first-page":"2896","article-title":"A systematic review of canine cystectomy: indications, techniques, and outcomes","volume":"13","author":"Hildebrandt I","year":"2023","unstructured":"Hildebrandt I, Culp WTN, Griffin MA. A systematic review of canine cystectomy: indications, techniques, and outcomes. Animals (Basel). 2023;13(18):2896. doi:10.3390\/ani13182896"},{"key":"ref2","article-title":"Withrow and MacEwen\u2019s Small Animal Clinical Oncology","author":"Withrow SJ","year":"2019","unstructured":"Withrow SJ, Vail DM, Page RL. Withrow and MacEwen\u2019s Small Animal Clinical Oncology. 6th ed. Elsevier; 2019."},{"issue":"4","key":"ref3","series-title":"J Vet Intern Med.","first-page":"273","article-title":"Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder","volume":"8","author":"Knapp DW","year":"1994","unstructured":"Knapp DW, Richardson RC, Chan TC,  Piroxicam therapy in 34 dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 1994;8(4):273-278. doi:10.1111\/j.1939-1676.1994.tb03232.x"},{"issue":"1","key":"ref4","series-title":"J Vet Intern Med.","first-page":"274","article-title":"Lower urinary tract transitional cell carcinoma in cats: clinical findings, treatments, and outcomes in 118 cases","volume":"34","author":"Griffin MA","year":"2020","unstructured":"Griffin MA, Culp WTN, Giuffrida MA,  Lower urinary tract transitional cell carcinoma in cats: clinical findings, treatments, and outcomes in 118 cases. J Vet Intern Med. 2020;34(1):274-282. doi:10.1111\/jvim.15656"},{"issue":"1","key":"ref5","series-title":"J Am Vet Med Assoc.","first-page":"101","article-title":"Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004)","volume":"231","author":"Wilson HM","year":"2007","unstructured":"Wilson HM, Chun R, Larson VS, Kurzman ID, Vail DM. Clinical signs, treatments, and outcome in cats with transitional cell carcinoma of the urinary bladder: 20 cases (1990-2004). J Am Vet Med Assoc. 2007;231(1):101-106. doi:10.2460\/javma.231.1.101"},{"issue":"4","key":"ref6","series-title":"Vet Comp Oncol.","first-page":"1417","article-title":"Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder","volume":"15","author":"Marvel SJ","year":"2017","unstructured":"Marvel SJ, S\u00e9guin B, Dailey DD, Thamm DH. Clinical outcome of partial cystectomy for transitional cell carcinoma of the canine bladder. Vet Comp Oncol. 2017;15(4):1417-1427. doi:10.1111\/vco.12286"},{"issue":"6","key":"ref7","series-title":"Mol Cancer Res.","first-page":"993","article-title":"Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer\u2014evidence for a relevant model system and urine-based diagnostic test","volume":"13","author":"Decker B","year":"2015","unstructured":"Decker B, Parker HG, Dhawan D,  Homologous mutation to human BRAF V600E is common in naturally occurring canine bladder cancer\u2014evidence for a relevant model system and urine-based diagnostic test. Mol Cancer Res. 2015;13(6):993-1002. doi:10.1158\/1541-7786.MCR-14-0689"},{"issue":"6","key":"ref8","series-title":"PLoS One.","first-page":"e0129534","article-title":"BRAF mutations in canine cancers","volume":"10","author":"Mochizuki H","year":"2015","unstructured":"Mochizuki H, Kennedy K, Shapiro SG, Breen M. BRAF mutations in canine cancers. PLoS One. 2015;10(6):e0129534. doi:10.1371\/journal.pone.0129534"},{"issue":"2","key":"ref9","series-title":"Vet Comp Oncol.","first-page":"73","article-title":"Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder","volume":"3","author":"Boria PA","year":"2005","unstructured":"Boria PA, Glickman NW, Schmidt BR,  Carboplatin and piroxicam therapy in 31 dogs with transitional cell carcinoma of the urinary bladder. Vet Comp Oncol. 2005;3(2):73-80. doi:10.1111\/j.1476-5810.2005.00070.x"},{"issue":"6","key":"ref10","series-title":"J Vet Intern Med.","first-page":"1385","article-title":"Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder","volume":"25","author":"Arnold EJ","year":"2011","unstructured":"Arnold EJ, Childress MO, Fourez LM,  Clinical trial of vinblastine in dogs with transitional cell carcinoma of the urinary bladder. J Vet Intern Med. 2011;25(6):1385-1390. doi:10.1111\/j.1939-1676.2011.00796.x"},{"issue":"10","key":"ref11","series-title":"J Small Anim Pract.","first-page":"480","article-title":"Partial cystectomy for urinary bladder neoplasia: surgical technique and outcome in 11 dogs","volume":"37","author":"Stone EA","year":"1996","unstructured":"Stone EA, George TF, Gilson SD, Page RL. Partial cystectomy for urinary bladder neoplasia: surgical technique and outcome in 11 dogs. J Small Anim Pract. 1996;37(10):480-485. doi:10.1111\/j.1748-5827.1996.tb01745.x"},{"issue":"3","key":"ref12","series-title":"J Vet Intern Med.","first-page":"145","article-title":"Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985)","volume":"6","author":"Norris AM","year":"1992","unstructured":"Norris AM, Laing EJ, Valli VE,  Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985). J Vet Intern Med. 1992;6(3):145-153. doi:10.1111\/j.1939-1676.1992.tb00330.x"},{"issue":"2","key":"ref13","series-title":"Can Vet J.","first-page":"133","article-title":"Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy","volume":"62","author":"Bradbury ML","year":"2021","unstructured":"Bradbury ML, Mullin CM, Gillian SD,  Clinical outcomes of dogs with transitional cell carcinoma receiving medical therapy, with and without partial cystectomy. Can Vet J. 2021;62(2):133-140."},{"issue":"2","key":"ref14","series-title":"Vet J.","first-page":"217","article-title":"Management of transitional cell carcinoma of the urinary bladder in dogs: a review","volume":"205","author":"Fulkerson CM","year":"2015","unstructured":"Fulkerson CM, Knapp DW. Management of transitional cell carcinoma of the urinary bladder in dogs: a review. Vet J. 2015;205(2):217-225. doi:10.1016\/j.tvjl.2015.01.017"},{"issue":"2","key":"ref15","series-title":"J Am Anim Hosp Assoc.","first-page":"131","article-title":"Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study","volume":"40","author":"Poirier VJ","year":"2004","unstructured":"Poirier VJ, Forrest LJ, Adams WM, Vail DM. Piroxicam, mitoxantrone, and coarse fraction radiotherapy for the treatment of transitional cell carcinoma of the bladder in 10 dogs: a pilot study. J Am Anim Hosp Assoc. 2004;40(2):131-136. doi:10.5326\/0400131"},{"issue":"11","key":"ref16","series-title":"J Am Vet Med Assoc.","first-page":"1534","article-title":"Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma","volume":"242","author":"Schrempp DR","year":"2013","unstructured":"Schrempp DR, Childress MO, Stewart JC,  Metronomic administration of chlorambucil for treatment of dogs with urinary bladder transitional cell carcinoma. J Am Vet Med Assoc. 2013;242(11):1534-1538. doi:10.2460\/javma.242.11.1534"},{"key":"ref17","article-title":"Tumors in Domestic Animals","author":"Meuten DJ","year":"2017","unstructured":"Meuten DJ, ed. Tumors in Domestic Animals. 5th ed. John Wiley and Sons; 2017."}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/264\/7\/javma.25.11.0721.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/264\/7\/javma.25.11.0721.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/264\/7\/javma.25.11.0721.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:15:53Z","timestamp":1781716553000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/264\/7\/javma.25.11.0721.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":34,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.2460\/javma.25.11.0721","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7,1]]}}}